首页 › 基金 › Atle Fund Management AB › MANE

Atle Fund Management AB 对 MANE 的持仓历史

Veradermics, Incorporated · 医疗保健

Atle Fund Management AB 在 Q3 2026 的 13F 申报中披露持有 MANE(Veradermics, Incorporated)10,106 股,市值约 US$1.2M,约占其申报组合的 0.33%,在其申报持仓中市值排名第 39 位。 Atle Fund Management AB 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)10.11K 股
申报持仓市值$1.23M
组合权重0.33%
首次申报Q3 2026
最近变动新进
更新于2026-11-12

最后更新: 2026-11-12 · 来源: SEC EDGAR Form 13F-HR

Atle Fund Management AB 对 MANE 的持仓演变

Atle Fund Management AB 于 Q3 2026 首次披露 MANE 持仓:10,106 股(约 US$1.2M)。

逐季持仓明细

季度股数金额变化
Q3 2026 10.11K $1.23M 新进

关于 MANE 与 13F 数据

MANE(Veradermics, Incorporated)属于医疗保健行业。我们追踪的基金中还有 185 只申报持有 MANE,申报仓位最大的包括:MONTANOVA CAPITAL, LLC (US$512.5M), SR ONE CAPITAL MANAGEMENT, LP (US$295.3M), Deep Track Capital, LP (US$245.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 MANE 的基金

查看 MANE 的全部基金持有人 →

常见问题

How long has Atle Fund Management AB held MANE?

Atle Fund Management AB has disclosed MANE holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Atle Fund Management AB's current position in MANE?

As of Q3 2026, Atle Fund Management AB holds 10.11K shares of MANE (Veradermics, Incorporated), valued at $1.23M, representing 0.33% of its reported portfolio and ranking #39.

Has Atle Fund Management AB been buying or selling MANE?

In the latest 13F filing (Q3 2026), Atle Fund Management AB newly opened its position in MANE.

Which other funds hold MANE?

Other major institutional holders of MANE include MONTANOVA CAPITAL, LLC, SR ONE CAPITAL MANAGEMENT, LP, Deep Track Capital, LP, among 185 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.